Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Multiple Sclerosis (Disease Or Phenotype)

Nci:C3243

Msh:D009103

Mondo:MONDO:5301

Medcin:MEDCIN:273834

Mdr:MDR:10039720

Id:3992a86f-eb66-5240-915e-8e669ae3f26f

Icpc2icd10eng:MTHU066602

Icd10cm:G35

Efo:EFO:803536

Doid:DOID:2377

Chv:CHV:8328

Results found

Linked to

	Label	Description
	Glatiramer acetate indication Multiple Sclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	betamethasone indication Multiple Sclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone Acetonide indication Multiple Sclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	SID11113806 indication Multiple Sclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Multiple Sclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	triamcinolone indication Multiple Sclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Teriflunomide indication Multiple Sclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	prednisolone indication Multiple Sclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone diacetate indication Multiple Sclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	methylprednisolone indication Multiple Sclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Glatiramer acetate indication Multiple Sclerosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

betamethasone indication Multiple Sclerosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone Acetonide indication Multiple Sclerosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

SID11113806 indication Multiple Sclerosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Multiple Sclerosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

triamcinolone indication Multiple Sclerosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Teriflunomide indication Multiple Sclerosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

prednisolone indication Multiple Sclerosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone diacetate indication Multiple Sclerosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

methylprednisolone indication Multiple Sclerosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.